Synth Med
Toronto, CA · 1 known investors
Find your way into Synth Med
Sign up to see every warm intro you have to Synth Med
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Synth Med team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Synth-Med develops a drug delivery platform that uses red blood cells to encapsulate therapeutic payloads in nanoparticles and target hard-to-reach tissues, with a lead program delivering a memory-enhancing molecule to the brain for Alzheimer's and other neurodegenerative diseases. The company operates in the biotech and therapeutics sector.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Synth Med do?
- Synth-Med develops a drug delivery platform that uses red blood cells to encapsulate therapeutic payloads in nanoparticles and target hard-to-reach tissues, with a lead program delivering a memory-enhancing molecule to the brain for Alzheimer's and other neurodegenerative diseases. The company operates in the biotech and therapeutics sector.
- Who founded Synth Med?
- Synth Med was founded by Sebastian Himbert.
- Who are Synth Med's investors?
- Synth Med's investors include Horizons Ventures.
- Where is Synth Med headquartered?
- Synth Med is headquartered in Toronto, CA.

